Royal Bank of Canada Reiterates Buy Rating for Xylem (XYL)

Xylem (NYSE:XYL)‘s stock had its “buy” rating restated by equities research analysts at Royal Bank of Canada in a report issued on Thursday. They currently have a $80.00 price target on the industrial products company’s stock. Royal Bank of Canada’s price objective points to a potential upside of 15.34% from the stock’s previous close.

A number of other equities analysts also recently weighed in on XYL. Seaport Global Securities reaffirmed a “buy” rating on shares of Xylem in a research report on Wednesday, November 1st. Cowen reaffirmed a “buy” rating and set a $70.00 price target on shares of Xylem in a research report on Thursday, September 21st. Canaccord Genuity reaffirmed a “hold” rating and set a $65.00 price target on shares of Xylem in a research report on Wednesday, November 1st. Robert W. Baird reaffirmed a “hold” rating and set a $67.00 price target on shares of Xylem in a research report on Wednesday, October 4th. Finally, Oppenheimer reaffirmed a “buy” rating on shares of Xylem in a research report on Tuesday, October 31st. Seven research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $65.92.

Shares of Xylem (XYL) traded up $0.46 on Thursday, hitting $69.36. The company had a trading volume of 796,500 shares, compared to its average volume of 817,833. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.76 and a quick ratio of 1.26. Xylem has a 1-year low of $46.67 and a 1-year high of $69.88. The firm has a market cap of $12,480.00, a price-to-earnings ratio of 40.33, a PEG ratio of 1.62 and a beta of 1.18.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, October 31st. The industrial products company reported $0.65 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.64 by $0.01. Xylem had a return on equity of 17.74% and a net margin of 6.85%. The business had revenue of $1.20 billion during the quarter, compared to analyst estimates of $1.18 billion. During the same period in the previous year, the firm earned $0.54 EPS. Xylem’s quarterly revenue was up 33.2% compared to the same quarter last year. research analysts anticipate that Xylem will post 2.39 EPS for the current fiscal year.

In other news, insider Colin R. Sabol sold 38,070 shares of the stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $65.81, for a total value of $2,505,386.70. Following the completion of the sale, the insider now owns 61,979 shares of the company’s stock, valued at approximately $4,078,837.99. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Steven R. Loranger sold 47,712 shares of the stock in a transaction that occurred on Monday, December 18th. The shares were sold at an average price of $68.10, for a total value of $3,249,187.20. Following the completion of the sale, the director now directly owns 68,843 shares of the company’s stock, valued at approximately $4,688,208.30. The disclosure for this sale can be found here. In the last three months, insiders sold 150,777 shares of company stock valued at $10,097,757. 0.75% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in Xylem by 0.3% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 13,352 shares of the industrial products company’s stock valued at $740,000 after acquiring an additional 39 shares during the period. Commerce Bank raised its stake in Xylem by 0.9% in the 2nd quarter. Commerce Bank now owns 10,672 shares of the industrial products company’s stock valued at $592,000 after acquiring an additional 90 shares during the period. Bluestein R H & Co. raised its stake in Xylem by 1.0% in the 2nd quarter. Bluestein R H & Co. now owns 10,100 shares of the industrial products company’s stock valued at $560,000 after acquiring an additional 100 shares during the period. Sentry Investment Management LLC raised its stake in Xylem by 1.2% in the 2nd quarter. Sentry Investment Management LLC now owns 11,839 shares of the industrial products company’s stock valued at $656,000 after acquiring an additional 137 shares during the period. Finally, Federated Investors Inc. PA raised its stake in Xylem by 5.8% in the 2nd quarter. Federated Investors Inc. PA now owns 3,286 shares of the industrial products company’s stock valued at $182,000 after acquiring an additional 181 shares during the period. Institutional investors and hedge funds own 85.04% of the company’s stock.

WARNING: This piece was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2018/01/04/royal-bank-of-canada-reiterates-buy-rating-for-xylem-xyl.html.

About Xylem

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply